Results
injected ICV (as above for 'Acute Li administration'). About half of the animals of each group received a subconvulsive dose of 100 mg/kg pilocarpine (Sigma-Aldrich, St. Louis, MO, dissolved, 10 mg/ml in saline) subcutaneously (s.c.) 15 minutes prior to sacrifice and brain extraction. Saline was injected in the control animals. Acute pilocarpine administration increased phosphoinositols labeling in whole brain and in combined cortex and hippocampus (3) . We now investigated (a) whether different brain regions, i.e. frontal-cortex and hippocampus, strongly implicated in mood regulation (4) , respond in a similar way to pilocarpine-induced phosphoinositols accumulation; (b) whether Li also hypersensitizes this neurochemical effect of pilocarpine; and (c) whether IMPA1-KO mice mimic the effect of Li treatment in their response to pilocarpine. None of the animals showed seizures prior to the time of sacrifice. In the frontal cortex both Li-treated and IMPA1-KO mice showed a nonsignificant ~40% trend towards increased phosphoinositols accumulation (Supplementary Fig. 2A ).
Pilocarpine further increased phosphoinositols accumulation (280% as compared with WT mice and 210% as compared with Li-treated mice) with no effect on the IMPA1-KOs (Supplementary Fig. 2A ).
In the hippocampus Li treatment and IMPA1-KO increased phosphoinositols labeling as compared with WT mice (200% and 70% increase, respectively, Supplementary Fig. 2B ) while pilocarpine had no effect ( Supplementary Fig. 2B ) suggesting brain region differential response to agonist stimulation (5) . Alternatively, the different results in the frontal-cortex and hippocampus might stem from a different distribution of muscarinic receptors in these brain regions (6) . Despite the similarity between IMPA1-KO mice and Li-treated mice in the hypersensitivity to pilocarpine-induced seizures (13) according to the manufacturer's instructions with slight modifications as we have previously described (8, 9) to avoid spontaneous seizures induced by the liposome suspensions. Reconstituted liposomes were mixed 1:5 with either aCSF or IP 3 followed by a short sonication for 5 sec using a Polytron cell homogenizer (Heat System Ultrasonic, Newtown, CT, USA) at 50% power capacity. Mice were tested in the FST 45 min following IP 3 administration (Supplementary Fig. S1A ). Based on the results of the dose-response experiment we selected the 150 µg IP 3 dose for later experiments.
We also carried out a dose-response experiment for the effect of 5, 10 and 30 pmoles of xestospongin-C in the FST. As previously reported (10), 30 pmoles xestospongin-C administered ICV in liposomes 45 min prior to the test reduced the immobility time ( Supplementary Fig. S3B ). Based on the results we selected the 10 pmole dose for later experiments because it was the highest dose that did not have an effect in the FST. Supplementary Fig. 4) . For the open field test mice were placed individually in monitor boxes (37.5x37.5x45cm) and their behavior digitally reordered.
Distance moved was analyzed using the Noldus EthoVision system (Wageningen, the Netherlands).
Neither IP 3 nor IP 1 affected motor activity in the open field test (Supplementary Fig. 4A, B) . For the beam walking test mice were placed on a beam at the end of which there was food and their home cage. We measured how long it took the mice to get to the food. The test ended when the mice reached Fig. 4C, D) . For the hanging-wire test each animal was placed on a metal grid that was gently shaken to cause a grabbing reflex, and slowly turned upside down. Latency to fall was counted during a session of 1 min, as previously described (11) . IP 3 but not IP 1 decreased their strength in this paradigm ( Supplementary Fig. 4E, F) . Hence, non-specific behavioral effects of IP 3 were ruled out because of the lack of the compound's effect in the open-field and the beam walking tests. The significant effect of IP 3 in the hanging wire test was disregarded since it was counterintuitive with respect to the FST results in which the mice were more, rather than less, mobile as compared with the control group. 
